Business Context and Reporting Period
This Form 8-K is a current report filed by CalciMedica, Inc. on June 23, 2023. The filing addresses corporate governance matters, specifically the scheduling of the company's 2023 Annual Meeting of Stockholders and the establishment of deadlines for shareholder proposals.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on administrative and governance events rather than financial performance.
Material Changes
There are no material financial changes reported in this document. The primary event is the Board of Directors' decision to set the date for the 2023 Annual Meeting to Wednesday, August 9, 2023, which is more than 30 days from the anniversary of the 2022 annual meeting.
Guidance, Outlook, and Governance Details
- Annual Meeting Date: August 9, 2023.
- Record Date: June 23, 2023 (for determining stockholders entitled to notice and vote).
- Shareholder Proposal Deadline: Due to the meeting date being more than 30 days from the prior anniversary, the deadline for submitting proposals under Rule 14a-8 is 5:00 p.m. Eastern Time on Friday, July 7, 2023.
- Submission Requirements: Proposals must be mailed to the Corporate Secretary at 505 Coast Boulevard South, Suite 307, La Jolla, CA, 92307 and must comply with Exchange Act rules and the Company's Bylaws.
- Universal Proxy Rules: Stockholders soliciting proxies for director nominees other than the Company's nominees must provide notice pursuant to Rule 14a-19.
Key Facts for Investor Verification
- Verify the exact date of the 2023 Annual Meeting (August 9, 2023) to ensure timely participation.
- Confirm the July 7, 2023 deadline for submitting shareholder proposals if intending to include items in the proxy materials.
- Review the upcoming 2023 Annual Meeting proxy statement for detailed information on director nominees and other agenda items.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.